Integrated Wealth Concepts’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB
Integrated Wealth Concepts's HZNP Position: Q4 2023 in Review
Integrated Wealth Concepts sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,155 shares — an estimated $249K sold.
Integrated Wealth Concepts first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $1.24M in Q2 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.
- Integrated Wealth Concepts reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Integrated Wealth Concepts sold 2,155 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $249K.
- Integrated Wealth Concepts first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
- Integrated Wealth Concepts's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.24M in Q2 2021.
- 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.
Based on Integrated Wealth Concepts's 13F filing for Q4 2023, filed 13 Feb 2024.